Results 221 to 230 of about 66,698 (357)

Safety and Tolerability of Withania somnifera Root Extract in Healthy Male Participants: A Pilot Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

open access: yesFood Science &Nutrition, Volume 14, Issue 1, January 2026.
Withania somnifera (WS) or Ashwagandha is valued for its anti‐inflammatory, antioxidant, adaptogenic, and memory‐enhancing properties. This randomized, placebo‐controlled and double‐blind study assessed the safety of standardized WS root extract in healthy adult participants over 180 days. The study concluded that WS root extract (200 mg capsules twice
Narendra Vaidya   +7 more
wiley   +1 more source

Prolactin secretion in patients with pituitary tumors [PDF]

open access: yes, 1974
Glöckner, B.   +5 more
core   +1 more source

Prognostic Significance of Solid Subtype of Papillary Thyroid Carcinoma: Analysis of 63 Patients

open access: yesHead &Neck, Volume 48, Issue 1, Page 5-12, January 2026.
ABSTRACT Objective Solid subtype of papillary thyroid carcinoma (SSPTC) is an uncommon subtype of papillary thyroid cancer (PTC) and its prognostic significance is still controversial. The aim of this review is to present the clinicopathological features of SSPTC and compare its clinical behavior with classical PTC (cPTC).
Andre Ywata de Carvalho   +3 more
wiley   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox   +46 more
wiley   +1 more source

Home - About - Disclaimer - Privacy